Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
04/2000
04/06/2000CA2344658A1 Human kinesin-like motor protein
04/06/2000CA2344561A1 Platelet-derived growth factor c, dna coding therefor, and uses thereof
04/06/2000CA2344274A1 Angiotensin converting enzyme homolog and its use
04/06/2000CA2343975A1 Ncam binding compounds
04/06/2000CA2343934A1 Short peptides which selectively modulate the activity of protein kinases
04/06/2000CA2343696A1 Membrane-associated organizational proteins
04/06/2000CA2342981A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
04/06/2000CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof
04/05/2000EP0989987A1 Spiro-azacyclic derivatives and their use as therapeutic agents
04/04/2000US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors
04/04/2000US6046329 Uracil derivatives
04/04/2000US6046242 Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
04/04/2000US6046219 Administering to the patient for treating the conditions mediated by collagen formation together with cell proliferation a hydroxypyridine derivative
04/04/2000US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
04/04/2000US6046183 Synergistic mixture of finasteride and doxazosin
04/04/2000US6046180 NAALADase inhibitors
04/04/2000US6046162 Suppression of cell proliferation by decorin
03/2000
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017204A1 INHIBITORS OF p38
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017176A2 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
03/30/2000WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000WO2000017143A1 Derivatives of phenantrene for medicinal use and a process for their preparation
03/30/2000WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
03/30/2000WO2000016760A2 New use of prostaglandin e2 antagonists
03/30/2000WO1999063931A9 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343918A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/29/2000EP0988379A1 Ldl-receptor
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988295A1 Heterocyclic substituted piperidines and uses thereof
03/29/2000EP0801554A4 Formulations and methods for reducing skin irritation
03/29/2000EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses
03/29/2000CN1248917A Method of treating prostatic diseases using active vitamin danalogues
03/29/2000CN1248467A Niaoshitong medicine for treating urolithiasis
03/29/2000CN1248453A Chinese-western synthetic medicine for treating lithiasis
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/28/2000US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes
03/28/2000US6043265 Isoxazolyl endothelin antagonists
03/28/2000US6043263 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043234 Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015220A1 A new composition
03/23/2000WO2000015218A1 A new composition
03/23/2000WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1999061418A3 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19843489A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors, useful for treatment of ischemia and other circulation disorders, tumors, prostatic hypertrophy and diabetic complications
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342341A1 A new composition
03/23/2000CA2342301A1 Human cell junction pdz protein
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/23/2000CA2342233A1 A new composition
03/23/2000CA2341440A1 Novel compounds
03/22/2000EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0986557A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986550A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986392A1 Method of treating chronic progressive vascular scarring diseases
03/22/2000EP0986385A1 Antagonists of gonadotropin releasing hormone
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1247751A Chinese medicine for treating calculus hydrops of liver, gall and kidney
03/21/2000US6040451 Used as analgesic, sedative and anaesthetic agents
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040324 Prophylactic or therapeutic drug for renal diseases
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/21/2000US6040309 Benzothiophene derivatives useful in therapy
03/21/2000US6040292 Methods for treating diabetes
03/21/2000US6040289 Active drug treating obesity
03/21/2000US6040133 D-enzyme compositions and methods of their use
03/21/2000US6039967 Intravesical drug delivery system
03/16/2000WO2000014235A1 Kunitz domain polypeptide zkun6